Karyopharm Therapeutics Inc. buy me8
Start price
05.02.24
/
0%
€1.35
Target price
05.02.25
-
Performance (%)
29.34%
End price
06.02.24
€1.75
Summary
This prediction ended on 06.02.24 with a price of €1.75. The BUY prediction by me8 finished with a performance of 29.34%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Karyopharm Therapeutics Inc. | -1.930% | -1.930% |
iShares Core DAX® | 1.665% | 1.692% |
iShares Nasdaq 100 | -0.475% | 1.483% |
iShares Nikkei 225® | 2.620% | 4.475% |
iShares S&P 500 | -0.091% | 1.099% |
According to me8 what are the pros and cons of Karyopharm Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Cons
Few uniques
Comments by me8 for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Buy Karyopharm Therapeutics Inc.
In the thread Trading Karyopharm Therapeutics Inc.
Buy beendet